MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, LXEO has $268,688K in assets. $22,019K in debts. $63,000K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1120.85%
Quick Ratio
1120.85%
Cash Ratio
374.82%
Debt to Asset Ratio
8.20%
Unit: Thousand (K) dollars
Assets Breakdown
    • Current portion of investments i...
    • Non-current portion of investmen...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-current portion of lease lia...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
63,000
Current portion of investments in u.s. treasury securities
118,767
Prepaid expenses and other current assets
6,625
Total current assets
188,392
Non-current portion of investments in u.s. treasury securities
64,801
Long-term investment
3,390
Restricted cash
3,248
Total property and equipment
1,880
Less accumulated depreciation
741
Property and equipment, net
1,139
Lease right-of-use assets - finance
1,140
Lease right-of-use assets - operating
6,578
Total assets
268,688
Accounts payable
4,856
Accrued expenses and other current liabilities
9,277
Current portion of lease liabilities - finance
518
Current portion of lease liabilities - operating
2,157
Total current liabilities
16,808
Non-current portion of lease liabilities - finance
327
Non-current portion of lease liabilities - operating
4,884
Total liabilities
22,019
Common stock, 0.0001 par value, 500,000,000 shares authorized as of december 31, 2025 73,001,766 shares issued and 73,001,350 shares outstanding as of december 31, 2025 500,000,000 shares authorized as of december 31, 2024 33,079,209 shares issued and 33,071,261 shares outstanding as of december 31, 2024
7
Treasury stock, at cost, 3,827 common shares as of december 31, 2025 and as of december 31, 2024
17
Additional paid-in capital
626,625
Accumulated other comprehensive gain (loss)
188
Accumulated deficit
-380,134
Total stockholders' equity
246,669
Total liabilities and stockholders' equity
268,688
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Current portion ofinvestments in u.s. treasury...$118,767K Cash and cashequivalents$63,000K Prepaid expenses andother current assets$6,625K Total property andequipment$1,880K Total current assets$188,392K Non-current portion ofinvestments in u.s. treasury...$64,801K Lease right-of-useassets - operating$6,578K Long-term investment$3,390K Restricted cash$3,248K Lease right-of-useassets - finance$1,140K Property and equipment,net$1,139K Less accumulateddepreciation$741K Total assets$268,688K Total liabilities andstockholders' equity$268,688K Total stockholders'equity$246,669K Total liabilities$22,019K Accumulated deficit-$380,134K Treasury stock, at cost,3,827 common shares as...$17K Additional paid-in capital$626,625K Total currentliabilities$16,808K Non-current portion of leaseliabilities - operating$4,884K Non-current portion of leaseliabilities - finance$327K Accumulated othercomprehensive gain (loss)$188K Common stock, 0.0001par value,...$7K Accrued expenses andother current...$9,277K Accounts payable$4,856K Current portion of leaseliabilities - operating$2,157K Current portion of leaseliabilities - finance$518K

Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics, Inc. (LXEO)